Schott

Schott Pharma to Build New US Prefillable Syringe Manufacturing Facility

In a move to triple its production of glass and polymer syringes for the US market by 2030, Germany’s Schott Pharma announced plans to build its first US facility to manufacture prefillable polymer syringes that meet the need for deep-cold storage and transportation of mRNA medications.

Schott Expands Footprint in "Pharmerging" Markets with Investment in Indonesia